Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Technology in Cancer Research & Treatment|July 15, 2017
Projected Improvements in Accelerated Partial Breast Irradiation Using a Novel Breast Stereotactic Radiotherapy Device: A Dosimetric AnalysisJames W Snider, Yildirim Mutaf, Elizabeth Nichols, et al.Journal of Applied Clinical Medical Physics|August 27, 2022
A study of skin marker alignment using different diamond-shaped light fields for prone breast external-beam radiation therapyHuijun Xu, Sally B Cheston, Arun Gopal, et al.Structure (London, England : 1993)|June 12, 2012
The crystal structure of the extracellular 11-heme cytochrome UndA reveals a conserved 10-heme motif and defined binding site for soluble iron chelatesMarcus J Edwards, Andrea Hall, Liang Shi, et al.Scientific Reports|June 28, 2022
Unprecedented frequency of mitochondrial introns in colonial bilateriansHelen Louise Jenkins, Rachael Graham, Joanne Sara Porter, et al.AIDS (London, England)|August 30, 2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapyMário Guimarães Pessôa, Brian Gazzard, Anna K Huang, et al.Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virusChristopher McGuigan, Karolina Madela, Mohamed Aljarah, et al.Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing|November 29, 2025
Measuring competency progression across the advanced practice nursing curriculum: A framework for continuous improvementHeather L Johnson, Regina P Owen, Kenneth Romito, et al.Radiation Research|October 16, 2020
Spatially Fractionated Radiotherapy (GRID) Prior to Standard Neoadjuvant Conventionally Fractionated Radiotherapy for Bulky, High-Risk Soft Tissue and Osteosarcomas: Feasibility, Safety, and Promising Pathologic Response RatesJames W Snider, Jason Molitoris, Susan Shyu, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2010
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virusChristopher McGuigan, Karolina Madela, Mohamed Aljarah, et al.Journal of Medicinal Chemistry|June 10, 2010
Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo propertiesChristopher McGuigan, Arnaud Gilles, Karolina Madela, et al.Pageof 4